Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
← Tools
Tools · FilingsUpdated with new filings

Japan AGM Voting Results & Director Approval

Annual meeting voting results, director support and shareholder dissent.

Data through · Updated with new filings

0

board nominees with under 80% support at 2026 meetings

The lowest was Astellas Pharma's nominee at 80.70%.

Lowest director approval

1
Download CSVAll selected filings

1 meeting · 9 board nominees, each meeting's lowest approval first

The line marks 80% approval.

Lowest director approval
DirectorProposalApprovalResultFiling
高原 茂季+8 other nominees, 93.20%–98.60%Astellas Pharma4503 · アステラス製薬Election of 3 audit committee directors
Original (Japanese)監査等委員である取締役3名選任の件
80.70%Votes cast: 80.75% · For 11,201,089 / Against 2,668,032 / Abstain 2,026ApprovedFiled  — filing S100YOHK

Rejected proposals

0

No stored data for this selection.

Shareholder proposals ≥ 20%

0

No stored data for this selection.

Approval is the ratio the company states (usually of the voting rights of shareholders present); votes cast are for ÷ (for + against + abstain).

† Percentage of votes cast; company did not state a ratio.

† Company-stated ratio differs from tallied votes.

All tools →